Orexigen Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 60   

Articles published

OREX 5.30 -0.08 (-1.49%)
price chart
Is Orexigen Attractive Near 52-Week Lows?
Orexigen saw a small run up over the past couple of months when the company filed application for approval in Europe and announced that it is anticipating an FDA decision in the United States this June.
Investor's Alert - Orexigen Therapeutics, Inc (NASDAQ:OREX), VIVUS, Inc ...
Las Vegas, NV - April 19, 2013 - (Tech Sonian) �Orexigen Therapeutics, Inc (NASDAQ:OREX) a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity.
Investor's Watch List - Pharmacyclics, Inc. (PCYC), Vertex Pharmaceuticals ...
Orexigen Therapeutics, Inc. (NASDAQ:OREX) announced corporate and financial results for the fourth quarter and year ended December 31, 2013.
Related articles »  
Front Runners: Orexigen Therapeutics, Inc. (OREX), MagneGas Corporation ...
Manhattan, NY- April 18, 2014 - (Techsonian) - Orexigen Therapeutics, Inc. (NASDAQ:OREX) announced corporate and financial results for the fourth quarter and year ended December 31, 2013.
Investor's Watch List -Orexigen Therapeutics, Inc., Mitsubishi UFJ Financial ...
Orexigen Therapeutics, Inc.(NASDAQ:OREX)plunged-7.40% and closed at $5.13 on a traded volume of 3.06 million shares, in comparison to 2.31 million shares of average trading volume.
Related articles »  
Drug Losers: Prana Biotechnology Limited (NASDAQ:PRAN), Orexigen ...
On March 12,2014 Orexigen�Therapeutics, Inc. (Nasdaq:OREX), a biopharmaceutical company focused on the treatment of obesity, announced corporate and financial results for the fourth quarter and year ended December 31, 2013.
Related articles »  
Stocks to Watch: Orexigen Therapeutics, Inc. (NASDAQ:OREX), Trina Solar ...
Las Vegas, NV - April 17, 2014 - (TechSonian) �Orexigen Therapeutics, Inc. (NASDAQ:OREX) a biopharmaceutical company focused on the treatment of obesity, reported corporate and financial results for the 4th quarter and year ended 31st December, ...
Related articles »  
News Review: Cloud Peak Energy Inc. (CLD), Orexigen Therapeutics, Inc ...
Cloud Peak Energy Inc. (NYSE:CLD) reported gain +1.82% and closed at $20.71 with the total traded volume of 1.05 million shares.
Stocks in Focus - Halcon Resources Corp (NYSE:HK), Orexigen Therapeutics ...
Orexigen Therapeutics, Inc (NASDAQ:OREX) a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity.
Related articles »  
Watch List: Array Biopharma Inc (ARRY), Orexigen Therapeutics, Inc. (OREX), Hi ...
Las Vegas, NV - April 11, 2014� (TechSonian) �Array Biopharma Inc (ARRY) focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases mainly in North America, ...
Related articles »